Rivacor 7 HF-T QP - Biventricular pacemaker/defibrillator Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

rivacor 7 hf-t qp - biventricular pacemaker/defibrillator

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with is4 port connecting a quadripolar lv lead, home monitoring functions, max. shock of 40j and df4/is4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are in the header. mr conditional. rivacor 7 hf-t qp belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt) through antitachycardia pacing (atp); in case of ineffective atp or hemodynamically not tolerated vts, with shock delivery ?cardiac resynchronization through multisite ventricular pacing ?compensation of bradycardia through av sequential pacing. hf-t qp devices with dx functionality are only indicated for patients not requiring atrial pacing. triple-chamber icds are indicated for patients with the following risks: ?sudden cardiac death caused by ventricular arrhythmias ?congestive heart failure with ventricular asynchrony

Trimacor 1000 mg Weichkapsel Բելգիա - գերմաներեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

trimacor 1000 mg weichkapsel

ibsa farmaceutici italia - eicosapentaensäure; docosahexaensäure; tocopherol-d-alpha - weichkapsel - 1000 mg - eicosapentaensäure 460 mg; docosahexaensäure 380 mg; tocopherol-d-alpha 4 mg - omega-3-triglycerides incl. other esters and acids

Biotronik Rivacor Implantable Cardioverter  Defibrillator Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

biotronik rivacor implantable cardioverter defibrillator

biotronik asia pacific pte. ltd. - cardiovascular - rivacor belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: termination of spontaneous ventricular fibrillation (vf) through shock delivery; termination of spontaneous ventricular tachycardia (vt) through antitachycardia pacing (atp); in case of ineffective atp or hemodynamically not tolerated vts, with shock delivery; cardiac resynchronization through multisite ventricular pacing (triple-chamber devices); compensation of bradycardia through ventricular (single-chamber devices) or av sequential pacing (dx, dual- and triple- chamber devices). vr-t dx and hf-t/hf-t qp devices types with dx functionality are only indicated for patients not requiring atrial pacing.

CEFTRIACOR 1g POLVO PARA SOLUCION INYECTABLE Պերու - իսպաներեն - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

ceftriacor 1g polvo para solucion inyectable

corval pharmaceutical s.a.c. - droguerÍa - polvo para solucion inyectable - por vial - - ceftriaxona